Literature DB >> 11483480

Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication.

H Cohen1, U Loewenthal, M Matar, M Kotler.   

Abstract

BACKGROUND: Antipsychotic medications cause a wide range of adverse effects and have been associated with sudden death in psychiatric patients. AIMS: To supply power spectral analysis of heart rate variability as a tool to examine the arrythmogenic effects of neuroleptics.
METHOD: Heart rate analysis was carried out in patients with schizophrenia on standard doses of neuroleptic monotherapy -- 21 were on clozapine, 18 on haloperidol and 17 on olanzapine -- and in 53 healthy subjects.
RESULTS: Patients with schizophrenia on clozapine had significantly higher heart rate, lower heart rate variability and lower high-frequency and higher low-frequency components compared with patients on haloperidol or olanzapine and matched control subjects. Prolonged QTc intervals were more common in patients than controls.
CONCLUSIONS: Patients treated with neuroleptic medications, especially clozapine, showed autonomic dysregulation and cardiac repolarisation changes. Physicians should be aware of this adverse reaction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483480     DOI: 10.1192/bjp.179.2.167

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  34 in total

1.  Blockade of HERG human K+ channels and IKr of guinea-pig cardiomyocytes by the antipsychotic drug clozapine.

Authors:  So-Young Lee; Young-Jin Kim; Kyong-Tai Kim; Han Choe; Su-Hyun Jo
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

Review 2.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

Review 3.  Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

Authors:  Karine Titier; Pierre-Olivier Girodet; Hélène Verdoux; Mathieu Molimard; Bernard Bégaud; Wilhelm Haverkamp; Malcolm Lader; Nicholas Moore
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Impact of Age and Sex on QT Prolongation in Patients Receiving Psychotropics.

Authors:  Simon W Rabkin
Journal:  Can J Psychiatry       Date:  2015-05       Impact factor: 4.356

Review 5.  Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.

Authors:  Kathlyn J Ronaldson
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

Review 6.  The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors:  Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

7.  The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.

Authors:  Jason G Ho; Randall L Caldwell; Christopher J McDougle; Danielle K Orsagh-Yentis; Craig A Erickson; David J Posey; Kimberly A Stigler
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-07-31       Impact factor: 2.576

8.  The pNNx Heart Rate Variability Statistics: An Application to Neuroautonomic Dysfunction of Clozapine-Treated Subjects.

Authors:  Jong-Hoon Kim; Sang Hoon Yi; Yong Min Ahn; Kyu Young Lee; Seung Ae Yang; Yong Sik Kim
Journal:  Psychiatry Investig       Date:  2009-11-09       Impact factor: 2.505

9.  Clozapine: Current perspective.

Authors:  Ram K Solanki; Paramjeet Singh; Mukesh K Swami
Journal:  Indian J Psychiatry       Date:  2007-10       Impact factor: 1.759

10.  Blood Pressure and Heart Rate Changes During Clozapine Treatment.

Authors:  Sarah M Norman; Kelli M Sullivan; Fang Liu; Bethany A DiPaula; Pedro A Jose; Christopher A Kitchen; Stephanie M Feldman; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.